{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:28:24Z","timestamp":1740144504163,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005436","name":"kymenlaakson rahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"kymi100 foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gelsolin amyloidosis (AGel amyloidosis) is a hereditary form of systemic amyloidosis featuring ophthalmological, neurological and cutaneous symptoms. Previous studies based mainly on patients\u2019 self-reporting have indicated that hearing impairment might also be related to the disease, considering the progressive cranial neuropathy characteristic for AGel amyloidosis. In order to deepen the knowledge of possible AGel amyloidosis-related hearing problems, a clinical study consisting of the Speech, Spatial and Qualities of Hearing Scale (SSQ) questionnaire, clinical examination, automated pure-tone audiometry and a speech-in-noise test was designed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the total 46 patients included in the study, eighteen (39%) had self-reported hearing loss. The mean scores in the SSQ were 8.2, 8.3 and 8.6 for the Speech, Spatial and Qualities subscales, respectively. In audiometry, the mean pure tone average (PTA) was 17.1 (SD 12.2) and 17.1 (SD 12.3) dB HL for the right and left ears, respectively, with no difference to gender- and age-matched, otologically normal reference values. The average speech reception threshold in noise (SRT) was\u2009\u2212\u20098.2 (SD 1.5) and\u2009\u2212\u20098.0 (SD 1.7) dB SNR for the right and left ears, respectively, which did not differ from a control group with a comparable range in PTA thresholds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although a significant proportion of AGel amyloidosis patients experience subjective difficulties in hearing there seems to be no peripheral or central hearing impairment at least in patients up to the age of 60\u00a0years.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-021-02077-9","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T19:02:37Z","timestamp":1635102157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hearing problems in patients with hereditary gelsolin amyloidosis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-3022","authenticated-orcid":false,"given":"Tuuli","family":"Mustonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville","family":"Sivonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Atula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Kiuru-Enari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saku T.","family":"Sinkkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,24]]},"reference":[{"key":"2077_CR1","first-page":"659","volume-title":"Handbook of clinical neurology (Vol 115)","author":"S Kiuru-Enari","year":"2013","unstructured":"Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. In: Said G, Krarup C, editors. Handbook of clinical neurology (Vol 115). Amsterdam: Elsevier B.V; 2013. p. 659\u201381."},{"issue":"8","key":"2077_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00417-014-2648-9","volume":"252","author":"J Gonzalez-Rodriguez","year":"2014","unstructured":"Gonzalez-Rodriguez J, Ramirez-Miranda A, Hernandez-Da Mota SE, Zenteno JC. TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies. Graefes Arch Clin Exp Ophthalmol. 2014;252(8):1267\u201372.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"2077_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4103\/0028-3886.125372","volume":"61","author":"BV Maramattom","year":"2013","unstructured":"Maramattom BV, Chickabasaviah YT. A new Indian family affected by gelsolin amyloidosis. Neurol India. 2013;61(6):673\u20135.","journal-title":"Neurol India"},{"issue":"1","key":"2077_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jns.12200","volume":"22","author":"A Sagnelli","year":"2017","unstructured":"Sagnelli A, Piscosquito G, Di Bella D, et al. Hereditary gelsolin amyloidosis (HGA): a neglected cause of bilateral progressive or recurrent facial palsy. J Peripher Nerv Syst. 2017;22(1):59\u201363.","journal-title":"J Peripher Nerv Syst"},{"key":"2077_CR5","doi-asserted-by":"crossref","unstructured":"Sridharan M, Highsmith WE, Kurtin PJ, et al. A patient with hereditary ATTR and a Novel AGel p.Ala578Pro amyloidosis. Mayo Clin Proc. 2018;93(11):1678\u201382.","DOI":"10.1016\/j.mayocp.2018.06.016"},{"issue":"2","key":"2077_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1159\/000479729","volume":"8","author":"F Lucero Saa","year":"2017","unstructured":"Lucero Saa F, Cremona FA, Minguez NX, Igarzabal ML, Chiaradia P. The first Argentinian family with familial amyloidosis of the Finnish type. Case Rep Ophthalmol. 2017;8(2):446\u201351.","journal-title":"Case Rep Ophthalmol"},{"issue":"1\u20132","key":"2077_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0014-5793(90)80510-P","volume":"276","author":"CP Maury","year":"1990","unstructured":"Maury CP, Kere J, Tolvanen R, de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 1990;276(1\u20132):75\u20137.","journal-title":"FEBS Lett"},{"key":"2077_CR8","doi-asserted-by":"crossref","unstructured":"Mustonen T, Schmidt EK, Valori M, Tienari PJ, Atula S, Kiuru-Enari S. Common origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families. Eur J Hum Genet. 2017.","DOI":"10.1038\/s41431-017-0026-x"},{"issue":"3","key":"2077_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/10409238.2012.661401","volume":"47","author":"JP Solomon","year":"2012","unstructured":"Solomon JP, Page LJ, Balch WE, Kelly JW. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol. 2012;47(3):282\u201396.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"sup1","key":"2077_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/13506129.2019.1582510","volume":"26","author":"F Boni","year":"2019","unstructured":"Boni F, Milani M, Mastrangelo E, Babiroli A, Diomede L, de Rosa M. An alternative non-proteolytic mechanism may underlie AGel amyloidosis. Amyloid. 2019;26(sup1):150\u20131.","journal-title":"Amyloid"},{"issue":"8","key":"2077_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1755-3768.2009.01686.x","volume":"87","author":"C Carrwik","year":"2009","unstructured":"Carrwik C, Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja\u2019s syndrome). Acta Ophthalmol. 2009;87(8):813\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"2077_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/mus.24922","volume":"53","author":"T Pihlamaa","year":"2016","unstructured":"Pihlamaa T, Salmi T, Suominen S, Kiuru-Enari S. Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis. Muscle Nerve. 2016;53(5):762\u20139.","journal-title":"Muscle Nerve"},{"issue":"6","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/PRS.0b013e318213a0a2","volume":"127","author":"T Pihlamaa","year":"2011","unstructured":"Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S. Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg. 2011;127(6):2342\u201351.","journal-title":"Plast Reconstr Surg"},{"key":"2077_CR14","doi-asserted-by":"crossref","unstructured":"Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand. 1992;86(4):346\u201353.","DOI":"10.1111\/j.1600-0404.1992.tb05099.x"},{"issue":"1","key":"2077_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0022-510X(94)90092-2","volume":"126","author":"S Kiuru","year":"1994","unstructured":"Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci. 1994;126(1):40\u20138.","journal-title":"J Neurol Sci"},{"issue":"2","key":"2077_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/ckj\/sft007","volume":"6","author":"S Yamanaka","year":"2013","unstructured":"Yamanaka S, Miyazaki Y, Kasai K, Ikeda S, Kiuru-Enari S, Hosoya T. Hereditary renal amyloidosis caused by a heterozygous G654A gelsolin mutation: a report of two cases. Clin Kidney J. 2013;6(2):189\u201393.","journal-title":"Clin Kidney J"},{"issue":"6","key":"2077_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/14017439709075953","volume":"31","author":"AL Fernandez","year":"1997","unstructured":"Fernandez AL, Herreros JM, Monzonis AM, Panizo A. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J. 1997;31(6):357\u20139.","journal-title":"Scand Cardiovasc J"},{"issue":"3","key":"2077_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF00225202","volume":"95","author":"RD Steiner","year":"1995","unstructured":"Steiner RD, Paunio T, Uemichi T, Evans JP, Benson MD. Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAP IV). Hum Genet. 1995;95(3):327\u201330.","journal-title":"Hum Genet"},{"issue":"3","key":"2077_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/13506129.2021.1911798","volume":"28","author":"T Mustonen","year":"2021","unstructured":"Mustonen T, Holkeri A, Holmstrom M, et al. Cardiac manifestations in Finnish gelsolin amyloidosis patients. Amyloid. 2021;28(3):168\u201372.","journal-title":"Amyloid"},{"issue":"6","key":"2077_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/07853890.2015.1075063","volume":"47","author":"T Nikoskinen","year":"2015","unstructured":"Nikoskinen T, Schmidt EK, Strbian D, Kiuru-Enari S, Atula S. Natural course of Finnish gelsolin amyloidosis. Ann Med. 2015;47(6):506\u201311.","journal-title":"Ann Med"},{"key":"2077_CR21","unstructured":"Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1(4):314\u2013324."},{"issue":"5","key":"2077_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/07853890.2016.1177197","volume":"48","author":"EK Schmidt","year":"2016","unstructured":"Schmidt EK, Atula S, Tanskanen M, Nikoskinen T, Notkola IL, Kiuru-Enari S. Causes of death and life span in Finnish gelsolin amyloidosis. Ann Med. 2016;48(5):352\u20138.","journal-title":"Ann Med"},{"issue":"1","key":"2077_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","volume":"15","author":"EK Schmidt","year":"2020","unstructured":"Schmidt EK, Mustonen T, Kiuru-Enari S, Kivela TT, Atula S. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet J Rare Dis. 2020;15(1):19\u201325.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2077_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00129492-200203000-00009","volume":"23","author":"I El-Sayed","year":"2002","unstructured":"El-Sayed I, Busaba NY, Faquin WC. Otologic manifestations of amyloidosis. Otol Neurotol. 2002;23(2):158\u20139.","journal-title":"Otol Neurotol"},{"issue":"4","key":"2077_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13506129.2019.1663814","volume":"26","author":"S Bartier","year":"2019","unstructured":"Bartier S, Bodez D, Kharoubi M, et al. Association between hearing loss and hereditary ATTR amyloidosis. Amyloid. 2019;26(4):234\u201342.","journal-title":"Amyloid"},{"issue":"2","key":"2077_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/13506129.2017.1330744","volume":"24","author":"E Bequignon","year":"2017","unstructured":"Bequignon E, Guellich A, Bartier S, et al. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Amyloid. 2017;24(2):96\u2013100.","journal-title":"Amyloid"},{"issue":"9","key":"2077_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1017\/S0022215106002155","volume":"120","author":"R Hornigold","year":"2006","unstructured":"Hornigold R, Patel AV, Ward VM, O\u2019Connor AF. Familial systemic amyloidosis associated with bilateral sensorineural hearing loss and bilateral facial palsies. J Laryngol Otol. 2006;120(9):778\u201380.","journal-title":"J Laryngol Otol"},{"issue":"5","key":"2077_CR28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.21534","volume":"41","author":"RJ Luttmann","year":"2010","unstructured":"Luttmann RJ, Teismann I, Husstedt IW, Ringelstein EB, Kuhlenbaumer G. Hereditary amyloidosis of the Finnish type in a German family: clinical and electrophysiological presentation. Muscle Nerve. 2010;41(5):679\u201384.","journal-title":"Muscle Nerve"},{"issue":"5","key":"2077_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MAJ.0b013e3181a4199c","volume":"337","author":"MM Shoja","year":"2009","unstructured":"Shoja MM, Ardalan MR, Tubbs RS, Kiuru-Enari S. Outcome of renal transplant in hereditary gelsolin amyloidosis. Am J Med Sci. 2009;337(5):370\u20132.","journal-title":"Am J Med Sci"},{"issue":"5","key":"2077_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1179\/174313209X409007","volume":"32","author":"K Makioka","year":"2010","unstructured":"Makioka K, Ikeda M, Ikeda Y, et al. Familial amyloid polyneuropathy (Finnish type) presenting multiple cranial nerve deficits with carpal tunnel syndrome and orthostatic hypotension. Neurol Res. 2010;32(5):472\u20135.","journal-title":"Neurol Res"},{"issue":"2","key":"2077_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14992020400050014","volume":"43","author":"S Gatehouse","year":"2004","unstructured":"Gatehouse S, Noble W. The speech, spatial and qualities of hearing scale (SSQ). Int J Audiol. 2004;43(2):85\u201399.","journal-title":"Int J Audiol"},{"issue":"7","key":"2077_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3109\/00016489.2014.898185","volume":"134","author":"A Dietz","year":"2014","unstructured":"Dietz A, Buschermohle M, Aarnisalo AA, et al. The development and evaluation of the Finnish Matrix Sentence Test for speech intelligibility assessment. Acta Otolaryngol. 2014;134(7):728\u201337.","journal-title":"Acta Otolaryngol"},{"issue":"Suppl 2","key":"2077_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/14992027.2015.1079929","volume":"54","author":"N Wardenga","year":"2015","unstructured":"Wardenga N, Batsoulis C, Wagener KC, Brand T, Lenarz T, Maier H. Do you hear the noise? The German matrix sentence test with a fixed noise level in subjects with normal hearing and hearing impairment. Int J Audiol. 2015;54(Suppl 2):71\u20139.","journal-title":"Int J Audiol"},{"key":"2077_CR34","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1121\/1.4877026","volume":"135","author":"P Zahorik","year":"2014","unstructured":"Zahorik P, Rothpletz A. Speech, spatial, and qualities of hearing scale (SSQ): normative data from young, normal-hearing listeners. J Acoust Soc Am. 2014;135:2163.","journal-title":"J Acoust Soc Am"},{"key":"2077_CR35","unstructured":"Acoustics: statistical distribution of hearing thresholds related to age and gender (ISO 7029:2017). 2017."},{"key":"2077_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.heares.2018.03.008","volume":"364","author":"H Guest","year":"2018","unstructured":"Guest H, Munro KJ, Prendergast G, Millman RE, Plack CJ. Impaired speech perception in noise with a normal audiogram: No evidence for cochlear synaptopathy and no relation to lifetime noise exposure. Hear Res. 2018;364:142\u201351.","journal-title":"Hear Res"},{"issue":"4","key":"2077_CR37","doi-asserted-by":"publisher","first-page":"846","DOI":"10.5114\/aoms.2013.39206","volume":"10","author":"W Pietruszewska","year":"2014","unstructured":"Pietruszewska W, Wagrowska-Danilewicz M, Klatka J. Amyloidosis of the head and neck: a clinicopathological study of cases with long-term follow-up. Arch Med Sci. 2014;10(4):846\u201352.","journal-title":"Arch Med Sci"},{"issue":"2","key":"2077_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1600-0560.2011.01812.x","volume":"39","author":"SF Wenson","year":"2012","unstructured":"Wenson SF, Jessup CJ, Johnson MM, Cohen LM, Mahmoodi M. Primary cutaneous amyloidosis of the external ear: a clinicopathological and immunohistochemical study of 17 cases. J Cutan Pathol. 2012;39(2):263\u20139.","journal-title":"J Cutan Pathol"},{"issue":"8","key":"2077_CR39","doi-asserted-by":"publisher","first-page":"e749","DOI":"10.1097\/MAO.0000000000001890","volume":"39","author":"S Sethi","year":"2018","unstructured":"Sethi S, Paner A, Okwuosa T, et al. Light chain amyloidosis presenting as bilateral external auditory canal obstructing masses. Otol Neurotol. 2018;39(8):e749\u201351.","journal-title":"Otol Neurotol"},{"issue":"1","key":"2077_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.anl.2013.04.009","volume":"41","author":"K Wasano","year":"2014","unstructured":"Wasano K, Saito H, Kanzaki S, Ogawa K. Keratinic amyloidosis of the external auditory canal. Auris Nasus Larynx. 2014;41(1):97\u2013100.","journal-title":"Auris Nasus Larynx"},{"key":"2077_CR41","doi-asserted-by":"publisher","unstructured":"Hosoi T, Dhaliwal G, Tokuda Y. Amyloidosis in bilateral external auditory canals. BMJ Case Rep. 2014;2014. https:\/\/doi.org\/10.1136\/bcr-200753.","DOI":"10.1136\/bcr-200753"},{"key":"2077_CR42","doi-asserted-by":"crossref","unstructured":"Gheriani H, Tewary R, O'Sullivan TJ. Amyloidosis of the external auditory canal and middle ear: unusual ear tumor. Ear Nose Throat J. 2007;86(2):92\u20133.","DOI":"10.1177\/014556130708600211"},{"key":"2077_CR43","doi-asserted-by":"crossref","unstructured":"Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report on three cases. Acta Pathol Microbiol Scand A. 1971;79(5):432\u2013440.","DOI":"10.1111\/j.1699-0463.1971.tb01841.x"},{"issue":"2","key":"2077_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/13506129609014366","volume":"3","author":"H Makishita","year":"1996","unstructured":"Makishita H, Ikeda S, Yazaki M, et al. Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid. 1996;3(2):134\u20139.","journal-title":"Amyloid"},{"issue":"2","key":"2077_CR45","doi-asserted-by":"publisher","first-page":"081","DOI":"10.3766\/jaaa.23.2.2","volume":"23","author":"J Banh","year":"2012","unstructured":"Banh J, Singh G, Pichora-Fuller MK. Age affects responses on the Speech, Spatial, and Qualities of Hearing Scale (SSQ) by adults with minimal audiometric loss. J Am Acad Audiol. 2012;23(2):081\u201391.","journal-title":"J Am Acad Audiol"},{"key":"2077_CR46","doi-asserted-by":"crossref","unstructured":"Gates GA, Mills JH. Presbycusis. Lancet. 2030;366(9491):1111\u201320.","DOI":"10.1016\/S0140-6736(05)67423-5"},{"key":"2077_CR47","unstructured":"H\u00e4rk\u00f6nen K, H\u00e4rk\u00f6nen K.Cochlear implantation in adults: extended indications and quality of life. 2018."},{"issue":"3","key":"2077_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/14992020903092608","volume":"49","author":"RH Margolis","year":"2010","unstructured":"Margolis RH, Glasberg BR, Creeke S, Moore BC. AMTAS: automated method for testing auditory sensitivity: validation studies. Int J Audiol. 2010;49(3):185\u201394.","journal-title":"Int J Audiol"},{"issue":"Suppl 2","key":"2077_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/14992027.2015.1020971","volume":"54","author":"B Kollmeier","year":"2015","unstructured":"Kollmeier B, Warzybok A, Hochmuth S, et al. The multilingual matrix test: principles, applications, and comparison across languages: A review. Int J Audiol. 2015;54(Suppl 2):3\u201316.","journal-title":"Int J Audiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T17:03:32Z","timestamp":1699722212000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02077-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2021,10,24]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee and the institutional research review board of the Helsinki University Hospital approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}